Impact of FSH Dosage During Ovarian Stimulation for IVF/ICSI on the Expression of FSH- and LH-receptors in Granulosa Cells
Overview
- Phase
- Phase 1
- Intervention
- Follitropin beta injection 150 IU
- Conditions
- Ovarian Function Insufficiency
- Sponsor
- ART Fertility Clinics LLC
- Enrollment
- 6
- Locations
- 1
- Primary Endpoint
- Number of FSHR- and LHR of the GC, obtained from one follicle on the morning of day 5, before the administration of the first GnRH-antagonist, punctured during the ovarian stimulation cycle
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
To study the influence of different daily rec-FSH dosages (150 IU versus 300 IU), performed in the same patient in consecutive cycles, on the relation between FSH- and LH-receptors of the granulosa cells of the growing follicle.
Detailed Description
This is a prospective cross-over study. Investigators want to study the effect of different dosages of recombinant FSH in the same patient on the expression of the FSH- and LH-receptors in the granulosa cells and on the endocrine milieu in the blood and the follicular fluid. An improved understanding of the mechanism leading to progesterone elevation might initiate a change in the ovarian stimulation approach, thereby not only preventing progesterone elevation and its negative consequences on ART (Assisted Reproductive Technology) outcome, but also improving individualization of the ovarian stimulation treatment according to the patients' characteristics.
Investigators
Barbara Lawrenz
Scientific Director
ART Fertility Clinics LLC
Eligibility Criteria
Inclusion Criteria
- •Desire to perform oocyte freezing for social fertility preservation, age 18 - 38 years
- •BMI of 18-32 kg/m2
- •Regular menstrual cycles with a length of 24-35 days
- •Anti-Muellerian-Hormone levels between 1.3 - 6.25 ng/ml (Ferraretti and Gianaroli, 2014; Calzada et al., 2019)
Exclusion Criteria
- •Occurrence of ovarian hyperstimulation syndrome (OHSS)
- •Occurrence of poor ovarian response (AFC \< 5 and AMH \< 0,5ng/ml) in previous ovarian stimulation treatment (20)
- •Polycystic ovary syndrome (PCOS) (21)
Arms & Interventions
Daily 150 IU recFSH
Follitropin beta injection 150 IU daily
Intervention: Follitropin beta injection 150 IU
Daily 300 IU recFSH
Follitropin beta injection 300 IU daily
Intervention: Follitropin beta injection 300 IU
Outcomes
Primary Outcomes
Number of FSHR- and LHR of the GC, obtained from one follicle on the morning of day 5, before the administration of the first GnRH-antagonist, punctured during the ovarian stimulation cycle
Time Frame: 5 days
Number of FSHR- and LHR of the GC, obtained from tone follicle of the size of 12 to 14 mm, when at least 2 to 3 follicles have reached a size of 12 to 14 mm, punctured during the ovarian stimulation cycle
Time Frame: 1 day
Number of FSHR- and LHR of the GC, obtained from two follicles (= pre-ovulatory follicle) on the morning of the day of final oocyte maturation, punctured during the ovarian stimulation cycle
Time Frame: 1 day
Number of FSHR- and LHR of the GC, obtained from the follicular fluid of follicles aspirated during OPU
Time Frame: 1 day
Secondary Outcomes
- Level of FSH hormone in the blood, on the day of OPU(1 day)
- Level of P4 hormone in the blood, on the day of OPU(1 day)
- Level of E2 hormone in the blood, the morning of day 5, before the administration of the first GnRH-antagonist(5 days)
- Level of P4 hormone in the blood, the morning of day 5, before the administration of the first GnRH-antagonist(5 days)
- Level of FSH hormone in the blood, the morning of day 5, before the administration of the first GnRH-antagonist(5 days)
- Level of LH hormone in the blood, the morning of day 5, before the administration of the first GnRH-antagonist(5 days)
- Level of E2 hormone in the blood, when there are at least 2 to 3 follicles with a size of 12 to 14 mm(1 day)
- Level of P4 hormone in the blood, when there are at least 2 to 3 follicles with a size of 12 to 14 mm(1 day)
- Level of FSH hormone in the blood, when there are at least 2 to 3 follicles with a size of 12 to 14 mm(1 day)
- Level of LH hormone in the blood, when there are at least 2 to 3 follicles with a size of 12 to 14 mm(1 day)
- Level of P4 hormone in the blood, on the morning of the day of final oocyte maturation(1 day)
- Level of E2 hormone in the blood, on the morning of the day of final oocyte maturation(1 day)
- Level of LH hormone in the blood, on the morning of the day of final oocyte maturation(1 day)
- Level of E2 hormone in the blood, on the day of OPU(1 day)
- Level of FSH hormone in the blood, on the morning of the day of final oocyte maturation(1 day)
- Level of P4 hormone in the follicular fluid of one follicle on the morning of day 5, before the administration of the first GnRH-antagonist(5 days)
- Level of FSH hormone in the follicular fluid of one follicle on the morning of day 5, before the administration of the first GnRH-antagonist(5 days)
- Level of LH hormone in the follicular fluid of one follicle on the morning of day 5, before the administration of the first GnRH-antagonist(5 days)
- Level of LH hormone in the blood, on the day of OPU(1 day)
- Level of E2 hormone in the follicular fluid of one follicle on the morning of day 5, before the administration of the first GnRH-antagonist(5 days)
- Level of E2 hormone in the follicular fluid of one follicle of the size of 12 to 14 mm, when at least 2 to 3 follicles have reached a size of 12 to 14 mm(1 day)
- Level of P4 hormone in the follicular fluid of one follicle of the size of 12 to 14 mm, when at least 2 to 3 follicles have reached a size of 12 to 14 mm(1 day)
- Level of FSH hormone in the follicular fluid of one follicle of the size of 12 to 14 mm, when at least 2 to 3 follicles have reached a size of 12 to 14 mm(1 day)
- Level of LH hormone in the follicular fluid of one follicle of the size of 12 to 14 mm, when at least 2 to 3 follicles have reached a size of 12 to 14 mm(1 day)
- Level of E2 hormone in the follicular fluid of two follicles (= pre-ovulatory follicle) on the morning of the day of final oocyte maturation(1 day)
- Level of P4 hormone in the follicular fluid of two follicles (= pre-ovulatory follicle) on the morning of the day of final oocyte maturation(1 day)
- Level of FSH hormone in the follicular fluid of two follicles (= pre-ovulatory follicle) on the morning of the day of final oocyte maturation(1 day)
- Level of LH hormone in the follicular fluid of two follicles (= pre-ovulatory follicle) on the morning of the day of final oocyte maturation(1 day)
- Level of E2 hormone in the follicular fluid of follicles aspirated during OPU(1 day)
- Level of P4 hormone in the follicular fluid of follicles aspirated during OPU(1 day)
- Level of FSH hormone in the follicular fluid of follicles aspirated during OPU(1 day)
- Level of LH hormone in the follicular fluid of follicles aspirated during OPU(1 day)